Calcium antagonist binding in cat brain tolerant to electroconvulsive shock

Area of Science:

• Neuroscience
• Pharmacology
• Neurobiology

Background:

• Electroconvulsive shock (ECS) is a treatment for severe depression.
• Tolerance to repeated ECS can develop in some species, like cats.
• The underlying neurobiological mechanisms of ECS tolerance are not fully understood.

Purpose of the Study:

• To investigate the effects of ECS on dihydropyridine (dihydropyridine) binding sites, specifically [3H] nitrendipine, in the brains of cats and rats.
• To explore the potential role of these binding sites in the development of ECS tolerance.

Main Methods:

• Cats were subjected to daily ECS for 25-30 days to induce tolerance.
• [3H] Nitrendipine binding assays were performed on brain regions (cerebral cortex, cerebellum, hippocampus) from tolerant and non-tolerant cats.
• Rats, which do not develop tolerance to ECS, were also studied following acute and chronic ECS.
• Binding density and affinity of [3H] nitrendipine were measured in rat brain regions at different time points post-ECS.

Main Results:

• In tolerant cats, ECS significantly increased [3H] nitrendipine binding density in the cerebral cortex and decreased its apparent affinity in the cerebellum.
• No significant changes in hippocampal binding were observed in cats.
• In rats, chronic ECS led to increased binding density in the cerebral cortex and hippocampus, but no changes in affinity.
• Acute ECS in rats did not alter [3H] nitrendipine binding in the cerebral cortex or hippocampus.

Conclusions:

• ECS significantly alters the density and/or affinity of [3H] nitrendipine binding sites in the central nervous system of both cats and rats.
• The observed changes in cerebellar [3H] nitrendipine binding in tolerant cats suggest a potential involvement in the development of ECS tolerance.
• Further research is needed to elucidate the precise role of dihydropyridine binding sites in ECS neurobiology.